ACRUX Ltd (ACR) - Total Liabilities
Based on the latest financial reports, ACRUX Ltd (ACR) has total liabilities worth AU$6.20 Million AUD (≈ $4.39 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore ACRUX Ltd (ACR) cash flow conversion to assess how effectively this company generates cash.
ACRUX Ltd - Total Liabilities Trend (2001–2025)
This chart illustrates how ACRUX Ltd's total liabilities have evolved over time, based on quarterly financial data. Check ACRUX Ltd liquid asset ratio to evaluate the company's liquid asset resilience ratio.
ACRUX Ltd Competitors by Total Liabilities
The table below lists competitors of ACRUX Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
McBride plc
LSE:MCB
|
UK | GBX411.00 Million |
|
Euro Kapital Yatirim Ortakligi AS
IS:EUKYO
|
Turkey | TL5.47 Million |
|
Syra Health Corp. Class A Common Stock
NASDAQ:SYRA
|
USA | $674.74K |
|
Real Estate Credit Investments Limited
LSE:RECI
|
UK | GBX117.51 Million |
|
EQTEC plc
LSE:EQT
|
UK | £9.22 Million |
|
Australasian Metals Ltd
AU:A8G
|
Australia | AU$210.16K |
|
Infomedia Press Limited
NSE:INFOMEDIA
|
India | Rs697.00 Million |
|
Elong Power Holding Limited Class A Ordinary Shares
NASDAQ:ELPW
|
USA | $46.58 Million |
Liability Composition Analysis (2001–2025)
This chart breaks down ACRUX Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see ACR stock market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.07 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.19 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 6.06 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.86 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how ACRUX Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for ACRUX Ltd (2001–2025)
The table below shows the annual total liabilities of ACRUX Ltd from 2001 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-06-30 | AU$6.20 Million ≈ $4.39 Million |
+9.06% |
| 2024-06-30 | AU$5.69 Million ≈ $4.02 Million |
+1.50% |
| 2023-06-30 | AU$5.60 Million ≈ $3.96 Million |
-9.38% |
| 2022-06-30 | AU$6.18 Million ≈ $4.37 Million |
+7.89% |
| 2021-06-30 | AU$5.73 Million ≈ $4.06 Million |
+1.04% |
| 2020-06-30 | AU$5.67 Million ≈ $4.01 Million |
+127.15% |
| 2019-06-30 | AU$2.50 Million ≈ $1.77 Million |
-0.87% |
| 2018-06-30 | AU$2.52 Million ≈ $1.78 Million |
-25.50% |
| 2017-06-30 | AU$3.38 Million ≈ $2.39 Million |
-64.34% |
| 2016-06-30 | AU$9.48 Million ≈ $6.71 Million |
+20.48% |
| 2015-06-30 | AU$7.87 Million ≈ $5.57 Million |
-29.51% |
| 2014-06-30 | AU$11.16 Million ≈ $7.90 Million |
+81.76% |
| 2013-06-30 | AU$6.14 Million ≈ $4.35 Million |
+13.83% |
| 2012-06-30 | AU$5.40 Million ≈ $3.82 Million |
-59.38% |
| 2011-06-30 | AU$13.28 Million ≈ $9.40 Million |
+323.57% |
| 2010-06-30 | AU$3.14 Million ≈ $2.22 Million |
-15.86% |
| 2009-06-30 | AU$3.73 Million ≈ $2.64 Million |
+18.02% |
| 2008-06-30 | AU$3.16 Million ≈ $2.23 Million |
+48.75% |
| 2007-06-30 | AU$2.12 Million ≈ $1.50 Million |
-19.92% |
| 2006-06-30 | AU$2.65 Million ≈ $1.88 Million |
+64.47% |
| 2005-06-30 | AU$1.61 Million ≈ $1.14 Million |
+19.52% |
| 2004-06-30 | AU$1.35 Million ≈ $954.23K |
+14.18% |
| 2003-06-30 | AU$1.18 Million ≈ $835.75K |
+35.69% |
| 2002-06-30 | AU$870.46K ≈ $615.91K |
+17.47% |
| 2001-06-30 | AU$741.00K ≈ $524.30K |
-- |
About ACRUX Ltd
Acrux Limited, together with its subsidiaries, develops and commercializes generic and topically applied pharmaceutical products in Australia, Europe, the United States, and internationally. The company provides estradiol transdermal sprays to women for the treatment of flushes associated with menopause under the Evamist and Lenzetto brand names; Dapsone 5% and Dapsone 7.5%, which are gels for th… Read more